Research Reports | Market Assessment
September 2020

Non-Small-Cell Lung Cancer – Current Treatment – Detailed Expanded Analysis: Treatment Sequencing (EU5)

Table of contents

  • Non-Small-Cell Lung Cancer - Current Treatment - Detailed Expanded Analysis: Treatment Sequencing (EU5)
    • Treatment Sequencing | Non-Small-Cell Lung Cancer | EU5 September 2020
Vandana, M.Pharm.
Vandana, M.Pharm.

Vandana Singh, M.Pharm., is an associate analyst on the Oncology team at Clarivate. Previously, she was a business analyst in digital marketing at Iquanti in Bangalore. She also conducted competitive intelligence, forecasting, and pipeline analysis at WNS in Noida. She obtained her master’s degree in pharmacology from the University of Delhi.

Login to access report
Back to all Market Assessment reports
Login to access report

launch Related Market Assessment Reports